Myriad: Myriad Genetics, INTERLINK Partner To Enhance Access To Hereditary Cancer Testing

WASHINGTON (dpa-AFX) - Myriad Genetics, Inc. (MYGN), a genetic and genomic tumor testing and precision medicine provider, and INTERLINK Care Management, Inc. announced Thursday an agreement design...